Vizsgálati helyszín
Sydvestjysk Sygehus
Esbjerg, 6700, DániaMég nincs intézményhez kötve
- 11futó vizsgálat
- 13lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 24 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis12 vizsgálat
- 4. fázis7 vizsgálat
- 2. fázis3 vizsgálat
- Állapot
- Lezárult12 vizsgálat
- Fut, nem toboroz7 vizsgálat
- Toboroz4 vizsgálat
- Leállították1 vizsgálat
- Fő szponzor
- Aarhus University Hospital2 vizsgálat
- Ionis Pharmaceuticals, Inc.2 vizsgálat
- Janssen Research & Development, LLC2 vizsgálat
- Odense University Hospital2 vizsgálat
- Amgen1 vizsgálat
- és még 15
Futó vizsgálatok
Toboroz
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
NCT07499232· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343· 3. fázis· Amgen· Forrás
Toboroz
Beneficial Effect of Amiloride on Progression of Chronic Kidney Disease
NCT06923709· 2. fázis· Odense University Hospital· Forrás
Toboroz
New treatments to reduce cardiovascular disease in type 1 diabetes
2023-505794-32-04· 3. fázis· Steno Diabetes Center Copenhagen· Forrás
Fut, nem toboroz
Bicarbonate for the treatment of cardiac arrest
2022-501304-10-00· 4. fázis· Aarhus University Hospital· Forrás
Fut, nem toboroz
Screening and intervention for subclinical coronary artery disease in patients with type 2 diabetes:
THE STENO INTEN-CT STUDY
2022-500143-21-01· 4. fázis· Aarhus University Hospital· Forrás
Fut, nem toboroz
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
NCT05681351· 3. fázis· Ionis Pharmaceuticals, Inc.· Forrás
Fut, nem toboroz
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
NCT05197049· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)
NCT04608318· 3. fázis· German CLL Study Group· Forrás
Toboroz
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
NCT04332822· 3. fázis· Nordic Lymphoma Group· Forrás
Toboroz
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
NCT03862859· 4. fázis· Nicholas Carlson· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Lezárult
A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes
NCT05901831· 3. fázis· Bayer· Forrás
Fut, nem toboroz
A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal Polyps
NCT05942222· 4. fázis· Copenhagen University Hospital, Rigshospitalet· Forrás
Lezárult
Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)
NCT05767034· 3. fázis· Novartis Pharmaceuticals· Forrás
Lezárult
MORPHINE PHARMACOKINETICS AND –DYNAMICS IN HEALTHY VOLUNTEERS AND PATIENTS WITH OBESITY AND OBSTRUCTIVE SLEEP APNOEA.
AN INVESTIGATOR INITIATED, CLINICAL STUDY OF THE IMPACT OF OBESITY AND SLEEP APNOEA ON THE PHARMACOLOGY OF MORPHINE
2022-500779-29-00· 2. fázis· Sydvestjysk Sygehus· Forrás
Lezárult
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke
NCT05643573· 3. fázis· Bayer AG· Forrás
Lezárult
A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia
NCT05610280· 3. fázis· Ionis Pharmaceuticals, Inc.· Forrás
Lezárult
A Study in Participants With Non-cirrhotic NASH With Fibrosis
NCT05638737· 2. fázis· AstraZeneca· Forrás
Lezárult
A Study of Population and Sex-specific Troponin Cutoffs for Ruling Out Acute Myocardial Infarction
NCT05336435· Herlev Hospital· Forrás
Lezárult
A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)
NCT05093933· 3. fázis· Merck Sharp & Dohme LLC· Forrás
Lezárult
Eosinophil-guided Reduction of Inhaled Corticosteroids
NCT04481555· 4. fázis· Chronic Obstructive Pulmonary Disease Trial Network, Denmark· Forrás
Lezárult
Optimal Peripheral Nerve Block After Minimally Invasive Colon Surgery
NCT04311099· 4. fázis· Claus Anders Bertelsen, PhD, MD· Forrás
Leállították
Comparing Mortality for Low vs High Peripheral Oxygen Saturation in COPD-patients With Acute Exacerbation
NCT04223050· 4. fázis· Esbjerg Hospital - University Hospital of Southern Denmark· Forrás
Lezárult
Quality of Life the Danish Multiple Myeloma Patients
NCT02892383· Odense University Hospital· Forrás
Hibát jelzek